Market Place
Sourcing Support
Ipca Labs Generic Levocetirizine Dihydrochloride Receives Approval in The US
06 May 2024 //
FDA
Apotex`s Generic Levocetirizine Dihydrochloride Receives Approval In US
04 May 2021 //
FDA
Hetero Lab`s Generic Levocetirizine Dihydrochloride Receives Approval in US
02 May 2020 //
FDA
FDA requires boxed warning for Singulair and its generics
05 Mar 2020 //
ENDPTS
FDA Requires Boxed Warning for Singulair, Generics
05 Mar 2020 //
RAPS
Only 37 drugs found to be NSQ out of 1,158 samples in CDSCO’s routine sample
12 Dec 2019 //
PHARMABIZ
Merck touts Phase III data for antibacterial Recarbrio
30 Sep 2019 //
ENDPTS
Glenmark Pharma receives approval from Russian Ministry to market Montlezir
30 Sep 2019 //
IIFL
Sanofi grabs non-prescription rights to Roche`s Tamiflu
23 Jul 2019 //
FIERCE PHARMA
Perrigo R&D Generic Levocetirizine Dihydrochloride Receives Approval in US
30 Mar 2019 //
FDA
Micro Labs` Generic Levocetirizine Dihydrochloride Receives Approval in US
21 Nov 2018 //
FDA
Apotex`s Generic Levocetirizine Dihydrochloride Receives Approval in US
13 Nov 2018 //
FDA
Tetra DP FDA Clearance of IND for Phase 2 Trial of BPN14770 in Fragile X Syn
16 Mar 2018 //
BUSINESSWIRE
Dr. Reddy`s Generic Levocetirizine Dihydrochloride Receives Approval In US
25 Jan 2018 //
FDA
Sanofi debuts first Xyzal ad campaign with wise old spokes-owl
20 Mar 2017 //
FIERCE PHARMA
Sanofi`s Xyzal® Allergy 24hr Approved For OTC Use In The United States
01 Feb 2017 //
PRESS RELEASE
Dr Reddy`s Lab completes acquisition of UCB`s select brands
19 Jun 2015 //
BUSINESS TODAY
UCB hands over South Asia branded drugs to Dr. Reddy`s in latest slimdown plan
01 Apr 2015 //
FIERCE PHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.